Robert W. Baird Lowers Owens & Minor (NYSE:OMI) Price Target to $24.00

Owens & Minor (NYSE:OMI - Get Free Report) had its price objective lowered by research analysts at Robert W. Baird from $28.00 to $24.00 in a research report issued to clients and investors on Monday, Benzinga reports. The firm presently has a "neutral" rating on the stock. Robert W. Baird's price target suggests a potential upside of 24.93% from the stock's previous close.

A number of other brokerages have also recently issued reports on OMI. SVB Leerink started coverage on Owens & Minor in a report on Monday, February 26th. They set a "market perform" rating and a $24.00 price objective for the company. Leerink Partnrs reissued a "market perform" rating on shares of Owens & Minor in a report on Monday, February 26th. Citigroup boosted their price target on Owens & Minor from $24.00 to $28.00 and gave the company a "neutral" rating in a research note on Tuesday, April 30th. TheStreet raised Owens & Minor from a "d+" rating to a "c-" rating in a report on Monday, March 4th. Finally, UBS Group cut their price objective on shares of Owens & Minor from $28.00 to $26.00 and set a "buy" rating for the company in a research report on Monday, January 29th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat, Owens & Minor currently has an average rating of "Hold" and an average price target of $23.29.

Owens & Minor Trading Up 5.5 %

Shares of OMI stock traded up $1.00 on Monday, reaching $19.21. 1,551,620 shares of the stock were exchanged, compared to its average volume of 674,550. The company has a debt-to-equity ratio of 2.17, a current ratio of 1.16 and a quick ratio of 0.56. Owens & Minor has a one year low of $13.64 and a one year high of $28.35. The stock has a market cap of $1.47 billion, a PE ratio of -37.67, a P/E/G ratio of 0.57 and a beta of 0.52. The stock has a 50 day moving average price of $25.35 and a 200 day moving average price of $21.49.

Owens & Minor (NYSE:OMI - Get Free Report) last issued its earnings results on Friday, May 3rd. The company reported $0.19 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.17 by $0.02. Owens & Minor had a positive return on equity of 12.97% and a negative net margin of 0.37%. The firm had revenue of $2.61 billion for the quarter, compared to analysts' expectations of $2.61 billion. During the same quarter last year, the business earned $0.05 earnings per share. The company's revenue was up 3.6% compared to the same quarter last year. Equities research analysts forecast that Owens & Minor will post 1.54 EPS for the current fiscal year.

Insider Activity at Owens & Minor

In other news, SVP Michael Wayne Lowry sold 10,000 shares of the company's stock in a transaction that occurred on Tuesday, February 27th. The stock was sold at an average price of $25.00, for a total value of $250,000.00. Following the completion of the transaction, the senior vice president now owns 71,654 shares of the company's stock, valued at $1,791,350. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In other news, SVP Jonathan A. Leon sold 5,000 shares of the firm's stock in a transaction dated Monday, April 22nd. The stock was sold at an average price of $24.84, for a total transaction of $124,200.00. Following the completion of the transaction, the senior vice president now directly owns 84,673 shares in the company, valued at $2,103,277.32. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Michael Wayne Lowry sold 10,000 shares of the stock in a transaction that occurred on Tuesday, February 27th. The shares were sold at an average price of $25.00, for a total transaction of $250,000.00. Following the sale, the senior vice president now directly owns 71,654 shares of the company's stock, valued at approximately $1,791,350. The disclosure for this sale can be found here. 2.62% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Owens & Minor

Several large investors have recently modified their holdings of the company. GAMMA Investing LLC boosted its position in Owens & Minor by 52.1% during the first quarter. GAMMA Investing LLC now owns 1,644 shares of the company's stock valued at $46,000 after acquiring an additional 563 shares during the last quarter. Rhumbline Advisers increased its stake in shares of Owens & Minor by 0.3% in the 3rd quarter. Rhumbline Advisers now owns 247,846 shares of the company's stock valued at $4,005,000 after acquiring an additional 660 shares in the last quarter. Quarry LP lifted its position in shares of Owens & Minor by 38.8% during the 4th quarter. Quarry LP now owns 2,573 shares of the company's stock valued at $50,000 after acquiring an additional 719 shares during the period. Riverview Trust Co bought a new position in Owens & Minor during the first quarter worth $25,000. Finally, Texas Permanent School Fund Corp grew its holdings in Owens & Minor by 1.8% in the first quarter. Texas Permanent School Fund Corp now owns 66,953 shares of the company's stock worth $1,855,000 after purchasing an additional 1,156 shares during the period. 98.04% of the stock is currently owned by institutional investors and hedge funds.

About Owens & Minor

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.